Nucleoredoxin antibody [N3C3]
GTX107039
ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
Product group Antibodies
ReactivityHuman, Mouse
TargetNXN
Overview
- SupplierGeneTex
- Product NameNucleoredoxin antibody [N3C3]
- Delivery Days Customer9
- ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.79 mg/ml
- ConjugateUnconjugated
- Gene ID64359
- Target nameNXN
- Target descriptionnucleoredoxin
- Target synonymsNRX, RRS2, TRG-4, nucleoredoxin, nucleoredoxin 1
- HostRabbit
- IsotypeIgG
- Protein IDQ6DKJ4
- Protein NameNucleoredoxin
- Scientific DescriptionFunctions as a redox-dependent negative regulator of the Wnt signaling pathway. May function as a transcriptional regulator. May regulate phosphatase 2A.
- ReactivityHuman, Mouse
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Arellanes-Robledo J, Ibrahim J, Reyes-Gordillo K, et al. Flightless-I is a potential biomarker for the early detection of alcoholic liver disease. Biochem Pharmacol. 2021,183:114323. doi: 10.1016/j.bcp.2020.114323Read this paper
- Alarcón-Sánchez BR, Guerrero-Escalera D, Rosas-Madrigal S, et al. Nucleoredoxin interaction with flightless-I/actin complex is differentially altered in alcoholic liver disease. Basic Clin Pharmacol Toxicol. 2020,127(5):389-404. doi: 10.1111/bcpt.13451Read this paper
- Arellanes-Robledo J, Reyes-Gordillo K, Ibrahim J, et al. Ethanol targets nucleoredoxin/dishevelled interactions and stimulates phosphatidylinositol 4-phosphate production in vivo and in vitro. Biochem Pharmacol. 2018,156:135-146. doi: 10.1016/j.bcp.2018.08.021Read this paper
- Arellanes-Robledo J, Reyes-Gordillo K, Shah R, et al. Fibrogenic actions of acetaldehyde are β-catenin dependent but Wingless independent: a critical role of nucleoredoxin and reactive oxygen species in human hepatic stellate cells. Free Radic Biol Med. 2013,65:1487-1496. doi: 10.1016/j.freeradbiomed.2013.07.017Read this paper



